Kidney Res Clin Pract.
2013 Jun;32(2):49-51.
Is VEGF a new therapeutic target for hypertension in chronic kidney disease?
- Affiliations
-
- 1Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea. yonsukim@snu.ac.kr
Abstract
- No abstract available.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Updated Guideline for Diagnosis of Hypertension in Chronic Kidney Disease Patients: Based on 2017 ACC/AHA Hypertension Guideline
- Hemodynamics and Pathophysiology of Hypertension in Different Stages of Chronic Renal Parenchymal Disease
- Decreased serum level and increased urinary excretion of vascular endothelial growth factor-C in patients with chronic kidney disease
- Role of VEGF in Kidney Development, Microvascular Maintenance and Pathophysiology of Renal Disease
- Hypertensive Retinopathy and Associated Target Organ Damage in Korean Hypertensive Patients
